Altor BioScience and CMC Biologics Announce Agreement for Manufacture Altor's ALT-803 - PR News

Press Release Distribution Service

Latest News from PR Log

Agriculture - Latest News

Automotive - Latest News

Biotech - Latest News

Computers - Latest News

Deals - Latest News

Defense - Latest News

Education - Latest News

Thursday, 13 April 2017

Altor BioScience and CMC Biologics Announce Agreement for Manufacture Altor's ALT-803

Altor's IL-15 Superagonist Molecule, ALT-803, is currently part of an extensive development program, including ongoing Phase 3 Clinical Trials

No comments:

Post a Comment

Electronics - Latest News